Survival benefit of chemoradiotherapy in limited-stage mantle cell lymphoma: a National Cancer Database analysis.
- DOI
- 10.1016/j.bneo.2026.100283
- Published
- 2026 Nov
- Container
- Blood neoplasia
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.bneo.2026.100283,
title = {Survival benefit of chemoradiotherapy in limited-stage mantle cell lymphoma: a National Cancer Database analysis.},
author = {Baccon D and Zhou J and Atallah-Yunes SA and Wang JF and Hwang SR and Paludo J and Munoz JL and Iqbal M and Breen WG and Lester SC and Micallef IN and Abeykoon JP and Klebig RR and Rosenthal AC and Moustafa MA and Chavez JC and Ansell SM and Habermann TM and Witzig TE and Nowakowski GS and Wang Y},
year = {2026},
journal = {Blood neoplasia},
doi = {10.1016/j.bneo.2026.100283},
url = {https://doi.org/10.1016/j.bneo.2026.100283}
}RIS
TY - JOUR TI - Survival benefit of chemoradiotherapy in limited-stage mantle cell lymphoma: a National Cancer Database analysis. AU - Baccon D AU - Zhou J AU - Atallah-Yunes SA AU - Wang JF AU - Hwang SR AU - Paludo J AU - Munoz JL AU - Iqbal M AU - Breen WG AU - Lester SC AU - Micallef IN AU - Abeykoon JP AU - Klebig RR AU - Rosenthal AC AU - Moustafa MA AU - Chavez JC AU - Ansell SM AU - Habermann TM AU - Witzig TE AU - Nowakowski GS AU - Wang Y PY - 2026 JO - Blood neoplasia DO - 10.1016/j.bneo.2026.100283 UR - https://doi.org/10.1016/j.bneo.2026.100283 ER -
APA
D, B., J, Z., SA, A., JF, W., SR, H., J, P., JL, M., M, I., WG, B., SC, L., IN, M., JP, A., RR, K., AC, R., MA, M., JC, C., SM, A., TM, H., TE, W., GS, N., & Y, W. (2026). Survival benefit of chemoradiotherapy in limited-stage mantle cell lymphoma: a National Cancer Database analysis.. Blood neoplasia. https://doi.org/10.1016/j.bneo.2026.100283
Source records
- pubmed · retrieved 2026-09-26T05:45:50.291Z